A major advance in cancer study is arising with the use of nanobodies to re-engage damaged p53. This vital malignant inhibitor protein is frequently inactivated in several forms of cancer, leading uncontrolled body https://bookmarkforest.com/story21863628/mini-antibodies-reactivate-tumor-suppressor-p53-new-promising-hope-for-cancer-therapy